|
paroxetine
|
CHEBI_7936 |
|
|
simultanagnosia
|
DOID_0060148 |
|
|
protein-losing enteropathy
|
DOID_10611 |
|
|
allergic urticaria
|
DOID_10612 |
|
|
IAP antagonist
|
CHEBI_229692 |
|
|
EC 2.6.1.40 [(R)-3-amino-2-methylpropionate--pyruvate transaminase] inhibitor
|
CHEBI_102368 |
|
|
pancreatic steatorrhea
|
DOID_10610 |
|
|
achalasia
|
DOID_9164 |
|
|
Creutzfeldt-Jakob disease
|
DOID_11949 |
|
|
mucocutaneous leishmaniasis
|
DOID_9155 |
|
|
gas gangrene
|
DOID_9159 |
|
|
primary hyperaldosteronism
|
DOID_446 |
|
|
Bartter disease
|
DOID_445 |
|
|
AMPA receptor antagonist
|
CHEBI_71014 |
|
|
pain agnosia
|
DOID_0060145 |
|
|
form agnosia
|
DOID_0060142 |
|
|
finger agnosia
|
DOID_0060141 |
|
|
neuromuscular disease
|
DOID_440 |
|
|
cortical deafness
|
DOID_0060140 |
|
|
autoimmune disease of the nervous system
|
DOID_438 |
|
